부산대학교 도서관

Briest, F; Noerenberg, D; Hennch, C; Yoshida, K; Hablesreiter, R; Nimo, J; Sasca, D; Kirchner, M; Mansouri, L; Inoue, Y

LEUKEMIA. 37(11):2237-2249

Noerenberg, D; Briest, F; Hennch, C; Yoshida, K; Hablesreiter, R; Takeuchi, Y; Ueno, H; Staiger, AM; Ziepert, M; Asmar, F

JOURNAL OF CLINICAL ONCOLOGY. 42(4):452-466

Schmiester M; Department of Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; BIH Biomedical Innovation Academy, Junior Clinician Scientist Program, Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Germany.; Freytag A; Department of Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Gillissen B; Department of Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Sträng E; Department of Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Hablesreiter R; Department of Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Richter A; Department of Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Striefler JK; Department of Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; von Laffert M; Institute of Pathology, Leipzig University, Leipzig, Germany.; Hummel M; Charité-Universitätsmedizin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Pathology, Berlin, Germany.; Jarosch A; Charité-Universitätsmedizin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Pathology, Berlin, Germany.; Kaul D; Department of Radiation Oncology, Health and Medical University Potsdam, Potsdam, Germany.; Ghadjar P; Department of Radiation Oncology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Öllinger R; Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Surgery, Berlin, Germany.; Rau D; Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Centre for Musculoskeletal Surgery, Berlin, Germany.; Märdian S; Department of Traumatology, Hand and Reconstructive Surgery, Rostock University Medical Center, Rostock, Germany.; Bullinger L; Department of Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Dolnik A; Department of Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Flörcken A; Department of Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.

Publisher: Informa Healthcare Country of Publication: England NLM ID: 8508395 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-5157 (Electronic) Linking ISSN: 02656736 NLM ISO Abbreviation: Int J Hyperthermia Subsets: MEDLINE

Stein CM; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Hematology, Oncology, and Cancer Immunology, Berlin, Germany.; Berlin School of Integrative Oncology (BSIO), Berlin, Germany.; Hablesreiter R; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Hematology, Oncology, and Cancer Immunology, Berlin, Germany.; Christen F; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Hematology, Oncology, and Cancer Immunology, Berlin, Germany.; Löwe P; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Hematology, Oncology, and Cancer Immunology, Berlin, Germany.; Berlin School of Integrative Oncology (BSIO), Berlin, Germany.; Fustero-Torre C; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Hematology, Oncology, and Cancer Immunology, Berlin, Germany.; Kopp K; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Hematology, Oncology, and Cancer Immunology, Berlin, Germany.; Locher BN; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Hematology, Oncology, and Cancer Immunology, Berlin, Germany.; Nitsch L; Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany.; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin Institute for Medical Systems Biology, Berlin, Germany.; Department of Biology, Chemistry, Pharmacy, Freie Universität Berlin, Berlin, Germany.; Altwasser R; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Hematology, Oncology, and Cancer Immunology, Berlin, Germany.; Kerschbaum JF; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Hematology, Oncology, and Cancer Immunology, Berlin, Germany.; Bullinger L; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Hematology, Oncology, and Cancer Immunology, Berlin, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Ludwig LS; Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany.; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin Institute for Medical Systems Biology, Berlin, Germany.; Strzelecka PM; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Hematology, Oncology, and Cancer Immunology, Berlin, Germany.; Damm F; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Hematology, Oncology, and Cancer Immunology, Berlin, Germany. frederik.damm@charite.de.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany. frederik.damm@charite.de.

Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

Wiegand L; Charité - Universitätsmedizin Berlin, Berlin, Germany.; Silva P; Charité Berlin, Berlin, Germany.; Noerenberg D; CVK Virchow Clinic, Charité Berlin, Berlin, Germany.; Christen F; Hannover Medical School, Hannover, Germany.; Kopp K; Charité - Universitätsmedizin Berlin, Berlin, Germany.; Locher BN; Charité - Universitätsmedizin Berlin, Berlin, Germany.; Löwe P; Charité, University Medical Center, Berlin, Germany.; Tilgner M; Charité - Universitätsmedizin Berlin, Berlin, Germany.; Altwasser R; Charité - Universitätsmedizin Berlin, Berlin, Germany.; Storzer V; Charité - Universitätsmedizin Berlin, Berlin, Germany.; Stein CM; Charité - Universitätsmedizin Berlin, Berlin, Germany.; Briest F; Charité - Universitätsmedizin Berlin, Berlin, Germany.; Arends CM; Charité, University Medical Center, Berlin, Germany.; Frick M; Charité - Universitätsmedizin Berlin, CVK, Berlin, Germany.; Ihlow J; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Dolnik A; Charité University Medicine, Berlin, Germany.; Ishaque N; Berlin Institute of Health (BIH) at Charité - Universitätsmedizin Berlin, Berlin, Germany, Berlin, Germany.; Keller U; Charite - Universitätsmedizin Berlin, Berlin, Germany.; Na IK; Charite-Universitaetsmedizin Berlin, Berlin, Germany.; Penter L; Charité - Universitätsmedizin Berlin, Berlin, Germany.; Bullinger L; Charité University Medicine, Berlin, Germany.; Hablesreiter R; Charité - Universitätsmedizin Berlin, Berlin, Germany.; Damm F; Charité - Universitätsmedizin Berlin, Berlin, Germany.

Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Hoyer, K. ; Hablesreiter, R. ; Inoue, Y. ; Yoshida, K. ; Briest, F. ; Christen, F. ; Kakiuchi, N. ; Yoshizato, T. ; Shiozawa, Y. ; Shiraishi, Y. ; Striefler, J.K. ; Bischoff, S. ; Lohneis, P. ; Putter, H. ; Blau, O. ; Keilholz, U. ; Bullinger, L. ; Pelzer, U. ; Hummel, M. ; Riess, H. ; Ogawa, S. ; Sinn, M. ; Damm, F.

In eBioMedicine April 2021 66

Al-Sawaf O; University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.; Locher BN; Charité - Universitätsmedizin Berlin, Berlin, Germany.; Christen F; Hannover Medical School, Hannover, Germany.; Hablesreiter R; Charité - Universitätsmedizin Berlin, Berlin, Germany.; Rajamani A; University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.; Robrecht S; University Hospital of Cologne, Köln, Germany.; Zhang C; University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.; Fink AM; University Hospital of Cologne, Cologne, Germany.; Tausch E; Ulm University, Ulm, Germany.; Schneider C; Ulm University, Ulm, Germany.; Ritgen M; Department of Internal Medicine II, University of Schleswig-Holstein, Kiel, Germany.; Kreuzer KA; Department I of Internal Medicine and Center of Integrated Oncology Aachen, Bonn, Cologne, Düsseldorf, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.; Kopp K; Charité - Universitätsmedizin Berlin, Berlin, Germany.; Mertz ME; Charité-Universitätsmedizin Berlin, Berlin, Germany.; Fustero-Torre C; 0000-0001-5504-4164), Berlin, Germany.; Kleo K; Charité-Universitätsmedizin Berlin, Berlin, Germany.; Seymour JF; Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, Australia.; Blombery P; Peter MacCallum Cancer Centre, Melbourne, Australia.; Bullinger L; Charité University Medicine, Berlin, Germany.; Chyla B; Abbvie, North Chicago, Illinois, United States.; Jin HY; Genentech Inc, San Francisco, California, United States.; Jiang Y; Genentech, Inc., South San Francisco, California, United States.; Stilgenbauer S; Ulm University, Ulm, Germany.; Hallek MJ; University of Cologne, Cologne, Germany.; Eichhorst BF; University of Cologne, Cologne, Germany.; Langerbeins P; University Hospital, Cologne, Germany.; Fischer K; University Hospital Cologne, Cologne, Germany.; Damm F; Charité - Universitätsmedizin Berlin, Berlin, Germany.

Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Hablesreiter R; Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Department of Hematology, Oncology and Cancer Immunology, Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.; Strzelecka PM; Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Department of Hematology, Oncology and Cancer Immunology, Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.; Kopp K; Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Department of Hematology, Oncology and Cancer Immunology, Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.; Estrada N; Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Department of Hematology, Oncology and Cancer Immunology, Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.; Dolnik A; Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Department of Hematology, Oncology and Cancer Immunology, Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.; Tilgner M; Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Department of Hematology, Oncology and Cancer Immunology, Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.; Fustero-Torre C; Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Department of Hematology, Oncology and Cancer Immunology, Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.; Thol F; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School (MHH), Hannover, Germany.; Heidel FH; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School (MHH), Hannover, Germany.; Leibniz Institute on Aging, Fritz-Lipmann-Institute, Jena, Germany.; Heuser M; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School (MHH), Hannover, Germany.; Department of Internal Medicine IV, University Hospital Halle (Saale), Martin-Luther-University Halle-Wittenberg, Halle, Germany.; Haghverdi L; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin Institute for Medical Systems Biology (BIMSB), Berlin, Germany.; Bullinger L; Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Department of Hematology, Oncology and Cancer Immunology, Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.; German Cancer Consortium (DKTK), Partner Site Berlin and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Christen F; Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Department of Hematology, Oncology and Cancer Immunology, Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.; Damm F; Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Department of Hematology, Oncology and Cancer Immunology, Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany. frederik.damm@charite.de.; German Cancer Consortium (DKTK), Partner Site Berlin and German Cancer Research Center (DKFZ), Heidelberg, Germany. frederik.damm@charite.de.

Publisher: BioMed Central Country of Publication: England NLM ID: 101590676 Publication Model: Electronic Cited Medium: Print ISSN: 2162-3619 (Print) Linking ISSN: 21623619 NLM ISO Abbreviation: Exp Hematol Oncol Subsets: PubMed not MEDLINE

Christen, F; Hoyer, K; Yoshida, K; Hou, H-A; Waldhueter, N; Heuser, M; Hills, RK; Chan, W; Hablesreiter, R; Blau, O; Ochi, Y; Klement, P; Chou, W-C; Blau, I-W; Tang, J-L; Zemojtel, T; Shiraishi, Y; Shiozawa, Y; Thol, F; Ganser, A; Löwenberg, B; Linch, DC; Bullinger, L; Valk, PJM; Tien, H-F; Gale, RE; Ogawa, S; Damm, F

Blood. 133:1140-1151

D. Noerenberg; F. Briest; C. Hennch; K. Yoshida; J. Nimo; R. Hablesreiter; Y. Takeuchi; D. Sasca; H. Ueno; L. Mansouri; Y. Inoue; L. Wiegand; A. M. Staiger; B. Casadei; M. Ziepert; F. Asmar; P. Korkolopoulou; M. Kirchner; P. Mertins; J. Weiner; E. Toth; T. Weber; A. Warth; T. Schneider; R.-M. Amini; W. Klapper; M. Hummel; V. Poeschel; G. Kanellis; A. Rosenwald; G. Held; E. Campo; K. Stamatopoulos; I. Anagnostopoulos; L. Bullinger; N. Goldschmidt; P. L. Zinzani; C. Bödor; R. Rosenquist; T. P. Vassilakopoulos; G. Ott; S. Ogawa; F. Damm

HemaSphere, Vol 6, Pp 2-3 (2022)

Arends CM; Department of Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Kopp K; Department of Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Hablesreiter R; Department of Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Estrada N; Department of Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Christen F; Department of Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Moll UM; Department of Pathology, Stony Brook University Cancer Center, Stony Brook, NY, 11794, USA.; Zeillinger R; Department of Obstetrics and Gynaecology, Molecular Oncology Group, Comprehensive Cancer Center-Gynaecologic Cancer Unit, Medical University of Vienna, Vienna, Austria.; Schmitt WD; Department of Pathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.; Sehouli J; Department of Gynaecology, European Competence Center for Ovarian Cancer, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Campus Virchow Klinikum, Berlin, Germany.; North Eastern German Society for Gynecological Cancer. Tumor Bank Ovarian Cancer Network, Berlin, Germany.; Kulbe H; Department of Gynaecology, European Competence Center for Ovarian Cancer, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Campus Virchow Klinikum, Berlin, Germany.; North Eastern German Society for Gynecological Cancer. Tumor Bank Ovarian Cancer Network, Berlin, Germany.; Fleischmann M; Klinik für Innere Medizin II, Abteilung Hämatologie und Onkologie, Universitätsklinikum Jena, Jena, Germany.; Ray-Coquard I; Centre Anticancereux Léon Bérard, University Claude Bernard Lyon, GINECO Group, Lyon, France.; Zeimet A; Department of Obstetrics and Gynecology, Medical University of Innsbruck, Austrian AGO, Innsbruck, Austria.; Raspagliesi F; Gynecologic Oncology Unit Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.; Zamagni C; Division of Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Vergote I; Division of Gynecological Oncology, Department of Gynecology and Obstetrics, Leuven Cancer Institute, Katholieke Universiteit Leuven, Leuven, Belgium.; Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Leuven, Belgium.; Lorusso D; Humanitas San Pio X, Humanitas University Rozzano, Milan, Italy.; Concin N; Department of Obstetrics and Gynecology, Medical University of Innsbruck, Austrian AGO, Innsbruck, Austria.; Bullinger L; Department of Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Braicu EI; Department of Gynaecology, European Competence Center for Ovarian Cancer, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Campus Virchow Klinikum, Berlin, Germany.; North Eastern German Society for Gynecological Cancer. Tumor Bank Ovarian Cancer Network, Berlin, Germany.; Damm F; Department of Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. frederik.damm@charite.de.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany. frederik.damm@charite.de.

Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

Arends CM; Department of Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Kopp K; Department of Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Hablesreiter R; Department of Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Estrada N; Department of Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Christen F; Department of Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Moll UM; Department of Pathology, Stony Brook University Cancer Center, Stony Brook, NY, 11794, USA.; Zeillinger R; Department of Obstetrics and Gynaecology, Molecular Oncology Group, Comprehensive Cancer Center-Gynaecologic Cancer Unit, Medical University of Vienna, Vienna, Austria.; Schmitt WD; Department of Pathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.; Sehouli J; Department of Gynaecology, European Competence Center for Ovarian Cancer, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Campus Virchow Klinikum, Berlin, Germany.; North Eastern German Society for Gynecological Cancer. Tumor Bank Ovarian Cancer Network, Berlin, Germany.; Kulbe H; Department of Gynaecology, European Competence Center for Ovarian Cancer, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Campus Virchow Klinikum, Berlin, Germany.; North Eastern German Society for Gynecological Cancer. Tumor Bank Ovarian Cancer Network, Berlin, Germany.; Fleischmann M; Klinik für Innere Medizin II, Abteilung Hämatologie und Onkologie, Universitätsklinikum Jena, Jena, Germany.; Ray-Coquard I; Centre Anticancereux Léon Bérard, University Claude Bernard Lyon, GINECO Group, Lyon, France.; Zeimet A; Department of Obstetrics and Gynecology, Medical University of Innsbruck, Austrian AGO, Innsbruck, Austria.; Raspagliesi F; Gynecologic Oncology Unit Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.; Zamagni C; Division of Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Vergote I; Division of Gynecological Oncology, Department of Gynecology and Obstetrics, Leuven Cancer Institute, Katholieke Universiteit Leuven, Leuven, Belgium.; Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Leuven, Belgium.; Lorusso D; Humanitas San Pio X, Humanitas University Rozzano, Milan, Italy.; Concin N; Department of Obstetrics and Gynecology, Medical University of Innsbruck, Austrian AGO, Innsbruck, Austria.; Bullinger L; Department of Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Braicu EI; Department of Gynaecology, European Competence Center for Ovarian Cancer, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Campus Virchow Klinikum, Berlin, Germany.; North Eastern German Society for Gynecological Cancer. Tumor Bank Ovarian Cancer Network, Berlin, Germany.; Damm F; Department of Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. frederik.damm@charite.de.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany. frederik.damm@charite.de.

Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE; PubMed not MEDLINE

Hablesreiter, Raphael ; Strzelecka, Paulina ; Estrada, Natalia ; Kopp, Klara ; Dolnik, Anna ; Tilgner, Marlon ; Fustero, Coral ; Thol, Felicitas R ; Heidel, Florian H. ; Heuser, Michael ; Bullinger, Lars ; Christen, Friederike ; Damm, Frederik

In Blood 5 November 2024 144 Supplement 1:2956-2956

Arends CM; Department of Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.; Liman TG; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.; Department of Neurology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Center for Stroke Research Berlin, Department of Experimental Neurology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Center for Neurodegenerative Diseases (Deutsches Zentrum für Neurodegenerative Erkrankungen), Partner Site, Berlin, Germany.; German Center for Cardiovascular Research (Deutsches Zentrum für Herz-Kreislauferkrankungen), Partner Site, Berlin, Germany.; Department of Neurology, Evangelical Hospital Oldenburg, Carl von Ossietzky-University, Oldenburg, Germany.; Strzelecka PM; Department of Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Kufner A; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.; Löwe P; Department of Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Huo S; Department of Neurology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Stein CM; Department of Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Piper SK; Department of Neurology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Institute of Biometry and Clinical Epidemiology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Institute of Medical Informatics, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Tilgner M; Department of Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Sperber PS; Center for Stroke Research Berlin, Department of Experimental Neurology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Experimental and Clinical Research Center, a Cooperation Between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin Berlin, Berlin, Germany.; NeuroCure Clinical Research Center, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Dimitriou S; Department of Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Heuschmann PU; Institute of Clinical Epidemiology and Biometry, University of Würzburg, Würzburg, Germany.; Comprehensive Heart Failure Center Würzburg, University of Würzburg, Würzburg, Germany.; Clinical Trial Center Würzburg, University Hospital Würzburg, Würzburg, Germany.; Hablesreiter R; Department of Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Harms C; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.; Department of Neurology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Center for Stroke Research Berlin, Department of Experimental Neurology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Center for Cardiovascular Research (Deutsches Zentrum für Herz-Kreislauferkrankungen), Partner Site, Berlin, Germany.; Bullinger L; Department of Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.; German Cancer Consortium (Deutsches Konsortium für Translationale Krebsforschung, DKTK), Partner Site, Berlin, Germany.; German Cancer Research Center (Deutsches Krebsforschungszentrum), Heidelberg, Germany.; Weber JE; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.; Department of Neurology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Endres M; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.; Department of Neurology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Center for Stroke Research Berlin, Department of Experimental Neurology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Center for Neurodegenerative Diseases (Deutsches Zentrum für Neurodegenerative Erkrankungen), Partner Site, Berlin, Germany.; German Center for Cardiovascular Research (Deutsches Zentrum für Herz-Kreislauferkrankungen), Partner Site, Berlin, Germany.; Damm F; Department of Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.; German Cancer Consortium (Deutsches Konsortium für Translationale Krebsforschung, DKTK), Partner Site, Berlin, Germany.

Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Arends CM; Department of Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Dimitriou S; Department of Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Stahler A; Department of Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Department of Medical Oncology and Comprehensive Cancer Center, University Hospital Grosshadern, Munich, Germany.; Hablesreiter R; Department of Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Strzelecka PM; Department of Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Stein CM; Department of Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Tilgner M; Department of Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Saiki R; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Ogawa S; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Bullinger L; Department of Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; German Cancer Consortium, Berlin, Germany; and.; German Cancer Research Center, Heidelberg, Germany.; Modest DP; Department of Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Stintzing S; Department of Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; German Cancer Consortium, Berlin, Germany; and.; German Cancer Research Center, Heidelberg, Germany.; Heinemann V; Department of Medical Oncology and Comprehensive Cancer Center, University Hospital Grosshadern, Munich, Germany.; Damm F; Department of Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; German Cancer Consortium, Berlin, Germany; and.; German Cancer Research Center, Heidelberg, Germany.

Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Christen F; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Hematology, Oncology, and Cancer Immunology, Berlin, Germany.; Hablesreiter R; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Hematology, Oncology, and Cancer Immunology, Berlin, Germany.; Hoyer K; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Hematology, Oncology, and Cancer Immunology, Berlin, Germany.; Hennch C; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Hematology, Oncology, and Cancer Immunology, Berlin, Germany.; Maluck-Böttcher A; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Hematology, Oncology, and Cancer Immunology, Berlin, Germany.; Segler A; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Gynecology with Center for Oncological Surgery, Berlin, Germany.; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Obstetrics, Berlin, Germany.; Madadi A; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Obstetrics, Berlin, Germany.; Frick M; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Hematology, Oncology, and Cancer Immunology, Berlin, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Bullinger L; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Hematology, Oncology, and Cancer Immunology, Berlin, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Briest F; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Hematology, Oncology, and Cancer Immunology, Berlin, Germany.; Damm F; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Hematology, Oncology, and Cancer Immunology, Berlin, Germany. frederik.damm@charite.de.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany. frederik.damm@charite.de.

Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

Frick, M.; Chan, W.; Arends, C. M.; Hablesreiter, R.; Halik, A.; Blau, O.; Heuser, M.; Michonneau, D.; Galan-Sousa, J.; Noerenberg, D.; Wais, V.; Stadler, M.; Yoshida, K.; Schetelig, J.; Schuler, E.; Thol, F.; Clappier, Emmanuelle; Christopeit, M.; Ayuk, F. A.; Bornhäuser, M.; Blau, I. W.; Ogawa, S.; Zemojtel, T.; Gerbitz, A.; Spriewald, B. M.; Schrezenmeier, H.; Kuchenbauer, F.; Kobbe, G.; Wiesneth, M.; Koldehoff, Michael; Socié, G.; Kröger, N.; Bullinger, L.; Thiede, C.; Damm, F.

Arends, Christopher Maximilian ; Kopp, Klara ; Estrada-Barreras, Natalia ; Hablesreiter, Raphael ; Concin, Nicole ; Moll, Ute ; Zeilinger, Robert ; Schmitt, Wolfgang ; Sehouli, Jalid ; Kulbe, Hagen ; Ray-Coquard, Isabelle ; Zeimet, Alain ; Raspagliesi, Francesco ; Zamagni, Claudio ; Vergote, Ignace ; Lorusso, Domenica ; Bullinger, Lars ; Braicu, Elena Ioana ; Damm, Frederik

In Blood 28 November 2023 142 Supplement 1:1317-1317

Frick M; 1 Charité - University Medical Center Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; 2 Berlin Institute of Health, Berlin, Germany.; Chan W; 1 Charité - University Medical Center Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; 2 Berlin Institute of Health, Berlin, Germany.; Arends CM; 1 Charité - University Medical Center Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; 2 Berlin Institute of Health, Berlin, Germany.; Hablesreiter R; 1 Charité - University Medical Center Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; 2 Berlin Institute of Health, Berlin, Germany.; Halik A; 1 Charité - University Medical Center Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; 2 Berlin Institute of Health, Berlin, Germany.; Heuser M; 3 Hannover Medical School, Hannover, Germany.; Michonneau D; 4 David Michonneau and Gérard Socié, INSERM U1160, Institut Universitaire d'Hematologie, Paris/University Paris Diderot, Paris, France.; Blau O; 1 Charité - University Medical Center Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; 2 Berlin Institute of Health, Berlin, Germany.; Hoyer K; 1 Charité - University Medical Center Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; 2 Berlin Institute of Health, Berlin, Germany.; Christen F; 1 Charité - University Medical Center Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; 2 Berlin Institute of Health, Berlin, Germany.; Galan-Sousa J; 1 Charité - University Medical Center Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; 2 Berlin Institute of Health, Berlin, Germany.; Noerenberg D; 1 Charité - University Medical Center Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; 2 Berlin Institute of Health, Berlin, Germany.; Wais V; 5 University Hospital Ulm, Ulm, Germany.; Stadler M; 3 Hannover Medical School, Hannover, Germany.; Yoshida K; 6 Kyoto University, Kyoto, Japan.; Schetelig J; 7 Carl Gustav Carus University Hospital Dresden, Dresden, Germany.; Schuler E; 8 Heinrich Heine University, Düsseldorf, Germany.; Thol F; 3 Hannover Medical School, Hannover, Germany.; Clappier E; 9 Saint Louis Hospital/University Paris Diderot, Paris, France.; Christopeit M; 10 University Hospital Eppendorf, Hamburg, Germany.; Ayuk F; 10 University Hospital Eppendorf, Hamburg, Germany.; Bornhäuser M; 7 Carl Gustav Carus University Hospital Dresden, Dresden, Germany.; Blau IW; 1 Charité - University Medical Center Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; 2 Berlin Institute of Health, Berlin, Germany.; Ogawa S; 6 Kyoto University, Kyoto, Japan.; Zemojtel T; 11 Berlin Institute of Health (BIH) Core Genomics Facility, Charité, University Medical Center, Berlin, Germany.; Gerbitz A; 1 Charité - University Medical Center Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; 2 Berlin Institute of Health, Berlin, Germany.; Wagner EM; 12 UCT Johannes Gutenberg University Mainz, Mainz, Germany.; Spriewald BM; 13 University Hospital Erlangen, Friedrich Alexander University Erlangen Nürnberg (FAU), Erlangen, Germany.; Schrezenmeier H; 14 German Red Cross Blood Transfusion Service Baden-Württemberg-Hessen and Institute of Transfusion Medicine, Ulm, Germany.; Kuchenbauer F; 5 University Hospital Ulm, Ulm, Germany.; Kobbe G; 8 Heinrich Heine University, Düsseldorf, Germany.; Wiesneth M; 14 German Red Cross Blood Transfusion Service Baden-Württemberg-Hessen and Institute of Transfusion Medicine, Ulm, Germany.; Koldehoff M; 15 West German Cancer Centre, University Hospital of Essen, University of Duisburg-Essen, Duisburg, Germany.; Socié G; 4 David Michonneau and Gérard Socié, INSERM U1160, Institut Universitaire d'Hematologie, Paris/University Paris Diderot, Paris, France.; Kroeger N; 10 University Hospital Eppendorf, Hamburg, Germany.; Bullinger L; 1 Charité - University Medical Center Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; 2 Berlin Institute of Health, Berlin, Germany.; 16 German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Thiede C; 7 Carl Gustav Carus University Hospital Dresden, Dresden, Germany.; 16 German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Damm F; 1 Charité - University Medical Center Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; 2 Berlin Institute of Health, Berlin, Germany.; 16 German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Frick, M; Chan, W; Arends, C. M; Hablesreiter, R.; Halik, A.; Blau, O.; Heuser, M.; Michonneau, D.; Galan-Sousa, J.; Noerenberg, D.; Wais, V; Stadler, M.; Yoshida, K.; Schetelig, J.; Schuler, E.; Thol, F.; Clappier, E.; Christopeit, M.; Ayuk, F. A.; Bornhaeuser, M.; Blau, I. W.; Ogawa, S.; Zemojtel, T.; Gerbitz, A.; Spriewald, B. M.; Schrezenmeier, H.; Kuchenbauer, F.; Kobbe, G.; Wiesneth, M.; Koldehoff, M.; Socie, G.; Kroeger, N.; Bullinger, L.; Thiede, C.; Damm, F.

ONCOLOGY RESEARCH AND TREATMENT; 2018, 41 p13-p13, 1p. Supplement: 4